BioCardia (BCDA) Cash from Operations Growth (5y) (2015 - 2026)
Powered by 
Analysis
BioCardia (BCDA) Cash from Operations Growth (5y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.02 Bn | 5.02 Bn | - |
| 3 | Iovance Biotherapeutics | 3.64 Bn | 3.34 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.56 Bn | 2.60 Bn | 251.50 Mn |
| 5 | uniQure | 3.01 Bn | 3.01 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.54 Bn | 2.54 Bn | - |
| 7 | Precigen | 2.36 Bn | 2.36 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.19 Bn | 1.40 Bn | 251.87 Mn |
| 9 | Vericel | 1.96 Bn | 1.80 Bn | 56.40 Mn |
| 10 | BioCardia | 13.18 Mn | 9.06 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.54% |
| Mar 31, 2026 | 2.50% |
| Dec 31, 2025 | 6.08% |
| Sep 30, 2025 | 14.24% |
| Jun 30, 2025 | 6.78% |
| Mar 31, 2025 | 11.58% |
| Dec 31, 2024 | 5.66% |
| Sep 30, 2024 | -12.14% |
| Jun 30, 2024 | 10.24% |
| Mar 31, 2024 | 9.10% |
| Dec 31, 2023 | 10.63% |
| Sep 30, 2023 | -3.72% |
| Jun 30, 2023 | -2.55% |
| Mar 31, 2023 | 3.35% |
| Dec 31, 2022 | -3.49% |
| Sep 30, 2022 | -2.45% |
| Jun 30, 2022 | -4.81% |
| Mar 31, 2022 | -5.04% |
| Dec 31, 2021 | -3.42% |
| Sep 30, 2021 | -18.38% |